Keywords: astex, million, alzheimer, collaboration, astrazeneca, cambridge, uk-based
Astex in $40 million Alzheimer's collaboration with AstraZeneca
Article | 10 March 2003
Cambridge, UK-based company Astex Technology, a specialist instructure-based drug design, has forged a collaboration with AstraZeneca which will see the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
